DISCOVERY OF A LIVER TARGETED ORAL PD-L1 SMALL MOLECULE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS B AND LIVER CANCER

被引：0
|
作者：
Roose, Heleen [1 ]
Rekstyte-Matiene, Kristina [1 ]
Stevens, Sarah K. [2 ]
Gupta, Kusum [2 ]
Chang, Sandra [2 ]
Liu, Cheng [2 ]
Serebryany, Vladimir [2 ]
Adame, Lillian [2 ]
Le, Kha [2 ]
Stoycheva, Antitsa [2 ]
Blatt, Lawrence M. [2 ]
Beigelman, Leonid N. [2 ]
Chanda, Sushmita [2 ]
Smith, David B. [2 ]
Symons, Julian [2 ]
Jekle, Andreas [2 ]
Wu, Tongfei [1 ]
机构：
[1] Aligos Belgium BV, Leuven, Belgium
[2] Aligos Therapeut Inc, San Francisco, CA USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1466-C
引用
收藏
页码：S566 / S567
页数：2
相关论文
共 50 条
  • [41] INTRAHEPATIC EXPRESSION OF PD-1, PD-L1 AND PD-L2 IN CHRONIC HEPATITIS B PATIENTS
    Chen, J.
    Lan, M. -D.
    Wu, X. -J.
    Zhao, J. -M.
    Lan, Z. -W.
    Wang, G-Q
    JOURNAL OF HEPATOLOGY, 2009, 50 : S205 - S205
  • [42] Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer
    Alkholifi, Faisal K.
    Alsaffar, Rana M.
    MEDICINA-LITHUANIA, 2022, 58 (11):
  • [43] SMALL-FOR-SIZE SYNDROME IS CHARACTERIZED WITH PD-L1 UPREGULATION IN MACROPHAGE AND BLOCKING PD-L1 ACCELERATES LIVER REGENERATION
    Shi, Ji-Hua
    Yan, Xin
    Cheng, Nuo
    Guo, Wen-Zhi
    Zhang, Shui-Jun
    TRANSPLANTATION, 2020, 104 (09) : S209 - S209
  • [44] Expression of PD-1, PD-L1 and PD-L2 within liver of autoimmune liver diseases
    Mataki, Norikazu
    Kikuchi, Kentaro
    Kawai, Toshihim
    Okada, Yoshikiyo
    Kurihara, Chic
    Watanabe, Chikako
    Kohmoto, Shunsuke
    Hokari, Ryota
    Kawaguchi, Atsushi
    Nagao, Shigeaki
    Kondo, Toshiro
    Itoh, Kazuro
    Miyakawa, Hiroshi
    Miura, Soichiro
    GASTROENTEROLOGY, 2006, 130 (04) : A280 - A280
  • [45] Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER export
    Chen, Fang-Fang
    Li, Zheng
    Ma, Dawei
    Yu, Qiang
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [46] YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer (vol 12, pg 2845, 2022)
    Lai, Fangfang
    Ji, Ming
    Huang, Lei
    Wang, Yunchen
    Xue, Nina
    Du, Tingting
    Dong, Kai
    Yao, Xiaoqing
    Jin, Jing
    Feng, Zhiqiang
    Chen, Xiaoguang
    ACTA PHARMACEUTICA SINICA B, 2023, 13 (07) : 3178 - 3179
  • [47] Preclinical characterization of potent and selective oral PD-L1 small-molecule antagonists
    Wang, Liang-Chuan S.
    Koblish, Holly
    Zhang, Yue
    Kulkarni, Ashwini
    Covington, Maryanne
    Gallagher, Karen
    Yang, Gengjie
    Rios-Doria, Jonathan
    Stevens, Christina
    Hansbury, Michael
    O'Connor, Sybil
    Yang, Yan-ou
    Diamond, Sharon
    Burke, Krista
    Xiao, Kaijiong
    Li, Jingwei
    Yao, Wenqing
    Wu, Liangxing
    Scherle, Peggy
    Hollis, Gregory
    Huber, Reid
    CANCER RESEARCH, 2019, 79 (13)
  • [48] Safety of PD 1/PD-L1 Blockade in Patients with Hepatitis B Infection and Advanced Cancer
    Chen, H.
    He, F.
    Wu, K.
    Han, W. D.
    Feng, L. L.
    Pang, X. L.
    Liu, S.
    Zheng, J.
    Ma, Y.
    Lan, P.
    Huang, M. J.
    Zou, Y. F.
    Yang, Z. L.
    Wang, T.
    Fan, X.
    Wan, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E634 - E634
  • [49] PET imaging of PD-L1 with a small molecule radiotracer
    Yajie Zhao
    Jessica C. Hsu
    Shuo Hu
    Weibo Cai
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1578 - 1581
  • [50] PET imaging of PD-L1 with a small molecule radiotracer
    Zhao, Yajie
    Hsu, Jessica C.
    Hu, Shuo
    Cai, Weibo
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1578 - 1581
12345